Dimenhydrinate 50 MG Oral Tablet

Known as: DIMENHYDRINATE 50 mg ORAL TABLET, COATED [Pac-Kit Motion Sickness], DIMENHYDRINATE 50 mg ORAL TABLET [Motion Sickness Relief Original Formula], DIMENHYDRINATE 50 mg ORAL TABLET, COATED [PhysiciansCare Dimenhydrinate Motion Sickness Relief] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1952-2017
01219522016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PURPOSE To investigate relationships between intravoxel incoherent motion (IVIM) metrics of invasive ductal carcinoma of the… (More)
Is this relevant?
2017
2017
PURPOSE We aimed to explore whether intravoxel incoherent motion (IVIM)-related parameters of hepatocellular carcinoma (HCC) and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2015
2015
To examine heterogeneous breast cancer through intravoxel incoherent motion (IVIM) histogram analysis. This HIPAA-compliant, IRB… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2015
Review
2015
AIMS Published incidences of acute mountain sickness (AMS) vary widely. Reasons for this variation, and predictive factors of AMS… (More)
Is this relevant?
1988
1988
Alpha-difluoromethylornithine (DFMO, eflornithine) is a specific irreversible inhibitor of ornithine decarboxylase, shown to be… (More)
Is this relevant?
1952
1952
 
Is this relevant?